Comparative Efficacy and Safety of Saroglitazar and Dapagliflozin on Hepatic Steatosis and Glycemic Control in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A 25‐Week Prospective Multicenter Comparative Cohort Study

Mukulesh Gupta, Kumar Prafull Chandra, Rajiv Awasthi, Arunkumar R. Pande, Nitin Ranjan Gupta, Vivek Agarwal, Dinesh Kumar
Endocrinology, Diabetes and Metabolism · Wiley · 2026-11-02 · DOI: 10.1002/edm2.70377

Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.

Читать у издателя →

Похожие статьи